Showing results (101-110 of 506) with videos related to
Sort By:
Pageof 51
Current Opinion in Pulmonary Medicine|March 3, 2023
Advances in development of new tuberculosis vaccinesChristopher da Costa, Philip Onyebujoh, Georges Thiry, et al.The Lancet. Infectious Diseases|March 28, 2018
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapiesSimon Tiberi, Nelita du Plessis, Gerhard Walzl, et al.Vaccine|February 6, 2025
Advancing local manufacturing capacities for vaccines within Africa - Opportunities, priorities and challengesJoachim Doua, Nicaise Ndembi, Jochen Auerbach, et al.Expert Review of Respiratory Medicine|August 24, 2011
Screening of immigrants in the UK for latent tuberculosisRuth McNerney, Giovanni Ferrara, Justin O'Grady, et al.Current Opinion in Pulmonary Medicine|March 16, 2012
Surgery and tuberculosisIan Cummings, Justin O'Grady, Vasudev Pai, et al.Current Opinion in Pulmonary Medicine|February 22, 2013
Advances in multiparametric molecular diagnostics technologies for respiratory tract infectionsKate Reddington, Nina Tuite, Thomas Barry, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 24, 2021
Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan AfricaJean B Nachega, Nathan Kapata, Nadia A Sam-Agudu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and VaccinesMarco Schito, Giovanni Battista Migliori, Helen A Fletcher, et al.Cell Stress|April 16, 2020
Coronavirus infections: Epidemiological, clinical and immunological features and hypothesesDidier Raoult, Alimuddin Zumla, Franco Locatelli, et al.The Journal of Antimicrobial Chemotherapy|March 29, 2014
Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in Gram-negative bacteria: is it time for a paradigm shift?Nina Tuite, Kate Reddington, Thomas Barry, et al.Pageof 51